Jaguar Health Announces Submission Of Clinical Trial Applications For Crofelemer To Treat Rare Disease Indications Microvillus Inclusion Disease And Short Bowel Syndrome In Europe
Jaguar's novel plant-based prescription drug crofelemer has been granted Orphan Drug Designation by the FDA and the European Medicines Agency for both MVID and SBSSAN FRANCISCO, CA / ACCESSWIRE / May 9, 2024 / Jaguar